Membership
Tour
Register
Log in
Mark Ian Lansdell
Follow
Person
Kent, GB
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
Patent number
8,138,188
Issue date
Mar 20, 2012
Pfizer Inc.
Mark David Andrews
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone deriv...
Patent number
7,649,002
Issue date
Jan 19, 2010
Pfizer Inc.
Andrew Antony Calabrese
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Compounds
Patent number
7,378,436
Issue date
May 27, 2008
Pfizer Inc.
Paul Vincent Fish
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines
Publication number
20090036459
Publication date
Feb 5, 2009
Pfizer Inc.
Mark David Andrews
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL COMPOUNDS
Publication number
20080306123
Publication date
Dec 11, 2008
Pfizer Inc.
Paul Vincent Fish
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
Publication number
20080269233
Publication date
Oct 30, 2008
Mark David Andrews
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Melanin Concentrating Hormone Receptor-1 Antagonist Pyridinones
Publication number
20080085884
Publication date
Apr 10, 2008
Pfizer Inc.
Duncan R. Armour
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Pharmaceutically active compounds
Publication number
20050176772
Publication date
Aug 11, 2005
Pfizer Inc.
Andrew Antony Calabrese
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Amide derivatives as selective serotonin re-uptake inhibitors
Publication number
20050014789
Publication date
Jan 20, 2005
Pfizer Inc.
Mark David Andrews
C07 - ORGANIC CHEMISTRY